Updated version 1 - According to the Financial Times, multiple private equity firms are exploring a deal to acquire International Paper’s European packaging business.
路透社2026/10/15 13:41Supplemented relevant information and details in paragraphs 3 and 4
Reuters, October 15 - According to a report by the Financial Times on Thursday, citing sources familiar with the matter, private equity firms Lone Star and Atlas Holdings are considering a bid to acquire International Paper's IP.N European packaging business, which is valued at less than $6 billion.
The company’s share price rose by 3%.
International Paper announced in January (link) that it would split into two publicly listed companies by spinning off its European packaging business, aiming to streamline operations and boost production efficiency in North America.
The company has not yet responded immediately to Reuters' request for comment.
(To assist non-native speakers of English, Reuters has automated this report's translation into several other languages. Automated translation may contain errors or lack the context required, and Reuters does not guarantee the accuracy of the automated translation. This service is provided solely for the convenience of readers. Reuters accepts no liability for any damage or loss caused by the use of automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Trump Media & Technology Group plunges over 24%, hitting a new low since listing.
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.